The Correlation of Skeletal and Cardiac Muscle Dysfunction in Duchenne Muscular Dystrophy

Andrew D Posner1, Jonathan H Soslow2, W Bryan Burnette3

  • 1Vanderbilt University, Nashville, TN, United States.

Insights

In Duchenne muscular dystrophy (DMD), maintained skeletal muscle strength correlates with better cardiac function. This relationship is significant in non-ambulatory patients, highlighting the need for cardiac monitoring in DMD research.

Area of Science:

  • Neurology
  • Cardiology
  • Genetics

Background:

  • Duchenne muscular dystrophy (DMD) involves progressive skeletal and cardiac muscle decline.
  • The link between skeletal and cardiac dysfunction progression in DMD is not fully understood.
  • Understanding this relationship is crucial for evaluating new DMD therapies' cardiac effects.

Purpose of the Study:

  • To investigate the association between worsening skeletal muscle weakness and the development of cardiac dysfunction in DMD patients.
  • To determine if skeletal muscle function predicts cardiac function in Duchenne muscular dystrophy.

Main Methods:

  • Studied 77 Duchenne muscular dystrophy patients, collecting data on muscle strength, cardiac function (fractional shortening), and medications.
  • Employed Spearman rank correlation and generalized least squares to analyze the relationship between muscle strength (subjective and quantitative muscle testing) and cardiac function.
  • Adjusted analyses for age, ambulatory status, and medication duration.

Main Results:

  • A significant correlation was found between maintained arm/leg muscle strength and preserved cardiac function (fractional shortening).
  • Quantitative muscle testing showed a significant association with cardiac function in non-ambulatory DMD subjects.
  • No significant association was observed between muscle testing and cardiac function in ambulatory DMD subjects.

Conclusions:

  • A significant relationship exists between skeletal muscle and cardiac function in non-ambulatory Duchenne muscular dystrophy patients.
  • This association suggests careful cardiac monitoring is warranted in DMD studies, even when cardiac function is not the primary outcome.
  • While not implying causation, the findings emphasize the interconnectedness of muscle systems in DMD.
Abstract

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.5K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
643
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
728
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
751
Specialized Characteristics of Cardiac Muscles01:27

Specialized Characteristics of Cardiac Muscles

The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy...
4.7K